SCI Pharmtech Inc
TWSE:4119
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
S
|
SCI Pharmtech Inc
TWSE:4119
|
TW |
|
H
|
Hyperdynamics Corp
OTC:HDYNQ
|
US |
|
Cable One Inc
NYSE:CABO
|
US |
|
Daiwa Securities Group Inc
TSE:8601
|
JP |
|
GS Yuasa Corp
TSE:6674
|
JP |
|
C
|
Cyrela Brazil Realty SA Empreendimentos e Participacoes
OTC:CYRBY
|
BR |
|
Phoenix New Media Ltd
NYSE:FENG
|
CN |
|
Genesis Metals Corp
XTSX:GIS
|
CA |
|
Societe Fonciere Lyonnaise SA
PAR:FLY
|
FR |
|
ABN Amro Bank NV
OTC:AAVMY
|
NL |
|
M
|
Meridian Bioscience Inc
LSE:0K0K
|
US |
|
S
|
Sonadezi Chau Duc Shareholding Co
VN:SZC
|
VN |
|
Saint Jean Groupe
PAR:SABE
|
FR |
|
Innovid Corp
NYSE:CTV
|
US |
|
S
|
SFP Tech Holdings Bhd
KLSE:SFPTECH
|
MY |
|
Blaze Minerals Ltd
ASX:BLZ
|
AU |
|
A
|
Attica Holdings SA
ATHEX:ATTICA
|
GR |
|
Sac's Bar Holdings Inc
TSE:9990
|
JP |
|
WeCommerce Holdings Ltd
XTSX:WE
|
CA |
|
A
|
Asia Pacific Investama Tbk PT
IDX:MYTX
|
ID |
|
Noumi Ltd
ASX:NOU
|
AU |
|
P
|
Plastikkart Akilli Kart Iletisim Sistemleri Sanayi ve Ticaret AS
IST:PKART.E
|
TR |
|
H
|
Heritage Cannabis Holdings Corp
CNSX:CANN
|
CA |
|
Surrozen Inc
NASDAQ:SRZN
|
US |
Relative Value
The Relative Value of one SCI Pharmtech Inc stock under the Base Case scenario is hidden TWD. Compared to the current market price of 52.3 TWD, SCI Pharmtech Inc is hidden .
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Multiples Across Competitors
Competitors Multiples
SCI Pharmtech Inc Competitors
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| TW |
S
|
SCI Pharmtech Inc
TWSE:4119
|
6.3B TWD | 4.5 | 54.1 | 16.5 | 42.3 | |
| US |
|
Eli Lilly and Co
NYSE:LLY
|
856.7B USD | 13.1 | 41.5 | 28 | 29.9 | |
| US |
|
Johnson & Johnson
NYSE:JNJ
|
566.8B USD | 6 | 21.1 | 14.7 | 18.1 | |
| CH |
|
Roche Holding AG
SIX:ROG
|
243.3B CHF | 4 | 18.9 | 11.2 | 12.6 | |
| UK |
|
AstraZeneca PLC
LSE:AZN
|
216.4B GBP | 4.9 | 28.3 | 15.7 | 22.1 | |
| US |
|
Merck & Co Inc
NYSE:MRK
|
282.6B USD | 4.3 | 15.5 | 9.6 | 11.7 | |
| CH |
|
Novartis AG
SIX:NOVN
|
222.2B CHF | 5.1 | 20.4 | 12.7 | 16.3 | |
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
237.1B USD | 102.3 | -81.1 | 375.3 | 941.3 | |
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.1T DKK | 3.4 | 10.3 | 7.7 | 9 | |
| US |
|
Pfizer Inc
NYSE:PFE
|
153.4B USD | 2.5 | 19.7 | 7.6 | 10.1 | |
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
115.7B USD | 2.4 | 16.4 | 7 | 8.6 |